Affamed.com

AffaMed蔼睦医疗

WebAffaMed Therapeutics Announces New Drug Application Acceptance by Singapore Health Sciences Authority (HSA) for DEXTENZA ® for Treatment of Ocular Inflammation and …

Actived: 4 days ago

URL: https://www.affamed.com/

AffaMed Therapeutics Announces New Drug Application …

WebAffaMed Therapeutics (“AffaMed”), a biotechnology company dedicated to developing and commercializing transformative pharmaceutical, and surgical products …

Category:  Health Go Health

AffaMed Therapeutics Announces Release of Headache Clinical …

WebThe World Health Organization calls for 90% of headache patients to receive standardized diagnosis and treatment at primary healthcare units. The Headache CDSS …

Category:  Health Go Health

AffaMed Therapeutics to commercialize Galcanezumab for …

WebAffamed to obtain sole commercialization rights upon regulatory approval in Mainland China to Galcanezumab, a monoclonal antibody that selectively binds to …

Category:  Health Go Health

VistaGen and AffaMed Complete Key Regulatory

WebSocial anxiety disorder affects as many as 23.7 million Americans and 188 million worldwide, including at least 11.3 million in China. 1,2,3 According to the National …

Category:  Health Go Health

AffaMed Therapeutics Announces the Establishment of AffaMed …

WebAffaMed Therapeutics (“AffaMed”), a global clinical-stage therapeutic company dedicated to developing and commercializing transformative pharmaceutical, digital and surgical …

Category:  Health Go Health

AffaMed Therapeutics Announces Approval to Initiate a Phase 3

WebAffaMed Therapeutics (“AffaMed”), a global biotechnology company dedicated to developing and commercializing transformative pharmaceutical, digital and …

Category:  Health Go Health

Milestones-AffaMed蔼睦医疗

Web中. Milestones. 2024. Feb. 2024. AffaMed Therapeutics Announces New Drug Application Acceptance by Singapore Health Sciences Authority (HSA) for DEXTENZA®for …

Category:  Health Go Health

AffaMed Therapeutics Announces Partner Vistagen Reports …

WebThe cross-national epidemiology of social anxiety disorder: Data from the World Mental Health Survey Initiative. BMC Med 15, 143 (2017). 3. Frost & Sullivan. …

Category:  Health Go Health

AffaMed Technologies Announces Successful Completion of First …

WebAffaMed Technologies (“AffaMed”), the joint venture established between AffaMed Therapeutics and SIFI S.p.A., to develop, manufacture and commercialize …

Category:  Health Go Health

Press Releases-AffaMed蔼睦医疗

WebPress Releases-AffaMed蔼睦医疗. 19. February 2024. AffaMed Therapeutics Announces New Drug Application Acceptance by Singapore Health Sciences Authority (HSA) for …

Category:  Health Go Health

AffaMed Therapeutics and SIFI Announce Joint

WebCataract is among the leading public health issues in China today, with the total prevalence estimated at over 100 million, but only approximately 4 million cataract …

Category:  Health Go Health

AffaMed Therapeutics Enters into Strategic

WebAffaMed Therapeutics (“AffaMed”), a global clinical stage biopharmaceutical company dedicated to addressing critical unmet medical needs in ophthalmic, …

Category:  Medical Go Health

AIER and AffaMed Therapeutics Reach Strategic Cooperation in …

WebJuly 22, 2022. AIER and AffaMed Therapeutics (“AffaMed”), a global clinical-stage biopharmaceutical company dedicated to developing and commercializing transformative …

Category:  Health Go Health

Careers-AffaMed蔼睦医疗

Web中. Careers. Values and Behaviors. At AffaMed, our employees are our most valuable assets. We come together every day to discover, develop and deliver new ways to …

Category:  Health Go Health

AffaMed蔼睦医疗

WebAffaMed蔼睦医疗是一家专注于眼科疾病创新治疗的生物制药公司,致力于帮助更多患者获得高效安全的药物。在这里,您可以了解我们的最新新闻和产品进展。

Category:  Health Go Health

VistaGen 与蔼睦医疗合作完成 PH94B PALISADE 全球三期临床试验 …

Web2020 年 6 月,蔼睦医疗与 VistaGen Therapeutics 达成战略许可和合作协议,获得在中国、韩国和东南亚地区进行 PH94B 临床开发和商业化的权益。. 截至目前, …

Category:  Health Go Health

蔼睦医疗宣布合作伙伴Vistagen的Fasedienol(PH94B)鼻喷剂在 …

Web2020年6月,蔼睦医疗与VistaGen签订了战略许可和合作协议,获得了PH94B在中国、韩国和东南亚的临床开发和商业化权益。. “我们很高兴3期临床试 …

Category:  Health Go Health

AffaMed Therapeutics 宣布完成逾 1.7 亿美元 B 轮融资-公司新闻 …

WebAffaMed Therapeutics 是一家创新生物制药公司,致力于开发和商业化具有革新价值的药物,以满足大中华地区和全球患者在眼科、神经和精神系统疾病治疗领域尚 …

Category:  Health Go Health

Careers-AffaMed蔼睦医疗

WebWe come together every day to discover, develop and deliver new ways to improve people’s health. Innovation. Guided by science to accelerate innovation. Patient Centricity. …

Category:  Health Go Health